CDC’s Division of Overdose Prevention hosted a webinar on the clinical and public health implications of medetomidine-involved opioid overdose and withdrawal. A recording of the webinar is available. Continuing education is free at CDC TRAIN.

Learn lessons from the field about the diagnosis and treatment of overdoses and withdrawal involving medetomidine mixed with opioids. Medetomidine is an emerging public health problem, and clinicians and public health agencies need to be aware of how shifts in the drug supply over time, such as the addition of adulterants like medetomidine, might change patient signs, symptoms, and management during opioid overdose or withdrawal.

Click Here to watch the webinar and learn more on the CDC's website.